Indication
Condylomata Acuminata
6 clinical trials
8 products
Clinical trial
An Observational Study to Compare Plateau Antibody Levels of a Recombinant (E.Coli) Human Papillomavirus Nonavalent (Type 6/11/16/18/31/33/45/52/58) Vaccine Versus Gardasil®9 in Healthy Females 18-26 Years of AgeStatus: Not yet recruiting, Estimated PCD: 2024-03-01
Product
Gardasil®9Clinical trial
Immunogenicity Non-inferiority Immuno-bridging Study of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58) Vaccine (E.Coli) in Healthy Population Aged 9-17 Years Old vs Aged 18-26 Years OldStatus: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
A Prospective, Exploratory Study to Evaluate the Efficacy of Peginterferon α-2b Injection Combined With Carbon Dioxide(CO2) Laser in the Treatment of Condylomata AcuminataStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Product
Peginterferon α-2bClinical trial
A Multicenter, Randomized, Double-Blind, Controlled (Bivalent Human Papillomavirus Vaccine (16,18 Type)(E. Coli)) Phase III Clinical Trial to Estimate Efficacy, Immunogenicity and Safty of the Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type) (E.Coli) in Healthy Women Aged 18 to 45 YearsStatus: Active (not recruiting), Estimated PCD: 2027-12-31
Product
Nonavalent HPV vaccineProduct
Bivalent HPV vaccineClinical trial
A PhaseⅡ Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 YearsStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Product
HPV VaccineProduct
HecolinClinical trial
Therapeutic Intralesional Nonavalent HPV Vaccine for Genital Condylomata in Adults: an Open Label Pilot StudyStatus: Recruiting, Estimated PCD: 2024-07-01